CEREVEL

Serial Number 88129519
Registration 6411727
700

Registration Progress

Application Filed
Sep 24, 2018
Under Examination
Apr 16, 2019
Approved for Publication
Feb 19, 2019
Published for Opposition
Feb 19, 2019
Registered
Jul 6, 2021

Trademark Image

CEREVEL

Basic Information

Serial Number
88129519
Registration Number
6411727
Filing Date
September 24, 2018
Registration Date
July 6, 2021
Published for Opposition
February 19, 2019
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Jul 6, 2021
Registration
Registered
Classes
005

Rights Holder

CEREVEL THERAPEUTICS, LLC

16
Address
222 Jacobs Street, Suite 200
Cambridge, MA 02141

Ownership History

Perception OpCo, LLC

Original Applicant
16
Boston, MA

CEREVEL THERAPEUTICS, LLC

New Owner Before Publication #1
16
BOSTON, MA

CEREVEL THERAPEUTICS, LLC

Owner at Publication
16
Cambridge, MA

CEREVEL THERAPEUTICS, LLC

Original Registrant
16
Cambridge, MA

Legal Representation

Attorney
Erica L Han

USPTO Deadlines

Next Deadline
515 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20210706)
Due Date
July 06, 2027
Grace Period Ends
January 06, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

38 events
Date Code Type Description Documents
Jul 6, 2021 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
May 29, 2021 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
May 28, 2021 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
May 1, 2021 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Apr 16, 2021 IUAF S USE AMENDMENT FILED Loading...
May 1, 2021 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Apr 16, 2021 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Apr 15, 2021 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Apr 15, 2021 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Apr 15, 2021 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Oct 17, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 15, 2020 EX3G S SOU EXTENSION 3 GRANTED Loading...
Oct 15, 2020 EXT3 S SOU EXTENSION 3 FILED Loading...
Oct 15, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 26, 2020 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Jun 26, 2020 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jun 26, 2020 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Apr 18, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 16, 2020 EX2G S SOU EXTENSION 2 GRANTED Loading...
Apr 16, 2020 EXT2 S SOU EXTENSION 2 FILED Loading...
Apr 16, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 17, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 15, 2019 EX1G S SOU EXTENSION 1 GRANTED Loading...
Oct 15, 2019 EXT1 S SOU EXTENSION 1 FILED Loading...
Oct 15, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 14, 2019 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Aug 14, 2019 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Aug 8, 2019 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Aug 8, 2019 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Apr 16, 2019 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Feb 19, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 19, 2019 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 30, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jan 9, 2019 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 6, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 31, 2018 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Sep 29, 2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Sep 27, 2018 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the prevention and treatment of central and peripheral nervous system diseases and disorders; pharmaceutical preparations for the prevention and treatment of neurological and neuropsychological diseases and disorders; pharmaceutical preparations for the prevention and treatment of medical conditions in the field of neuroscience
First Use Anywhere: Dec 1, 2020
First Use in Commerce: Dec 1, 2020

Classification

International Classes
005